Voriconazole

5 trials 3 recruiting JAnti-infectives

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

1 Completed trials

5 Sponsors

9 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Oversight events:

7 temporary halts across 1 trial

View oversight register →

Indications tested

Fungal infection 2 Aspergillus infection 1 Scedosporium infection 1 Fusarium infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Basilea Pharmaceutica International AG Allschwil 1 Centre Hospitalier Universitaire De Nantes 1 Elion Therapeutics Inc. 1 Scynexis Inc. 1

All trials

5 total

CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Phase 2 EL219 versus Liposomal Amphotericin B for Early Antifungal Therapy Recruiting

2025-522835-32-00 Phase II 4 countries Elion Therapeutics Inc.
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole al… Recruiting

2024-517004-11-00 Phase III 1 country Centre Hospitalier Universitaire De Poitiers
Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus I… Ended

2024-511755-18-00 Phase III 7 countries Scynexis Inc.

Showing 1–5 of 5 trials

← All drugs A–Z